|
|
Article: Phase I human clinical testing of SARS vaccine update offered.
- Article from:
- Biotech Week
- Article date:
- October 6, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Sinovac Biotech Ltd. (Sinovac) (OTCBB:SNVBF) announced that all 36 subjects of the phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with two doses of either SARS vaccine or placebo.
The immunization schedule for the trial is now complete.
The final 6 subjects in the second group of 18 volunteers received their second vaccination on the 1st September 2004. No adverse side effects were observed during the 72-hour observation period after this second inoculation. Blood sampling from these final six subjects has been completed. The second group of 18 volunteers has been injected ...